临床试验启动流程:意大利公立医院的案例研究
该研究对意大利亚历山德里亚公立医院研究与创新部(DAIRI)的试验启动流程进行重组,采用精益思维(Lean Thinking)和A3报告工具,监测8个4个月周期的关键绩效指标。共监测298项研究,试验启动平均时间从项目前的218天降至最后监测期的56天,各参与部门平均耗时至少减半。作者认为重组项目强调了培训临床与行政人员的重要性,并制定了标准操作程序和时间监测工具,可在其他临床中心实施。
要点
- 采用精益思维与A3报告工具重组试验启动流程,监测298项研究。
- 试验启动平均时间从项目前218天降至最后监测期56天。
- 各参与部门平均耗时至少减半,但签署协议的研究启动时间仍长于未签署协议者(100天 vs 46天)。
核心结论
- 重组项目强调了拥有专门培训的临床与行政人员对试验启动流程的重要性,并制定了标准操作程序和时间监测工具(流程KPI),可在其他临床中心实施。
研究设计与样本
- 对意大利亚历山德里亚公立医院研究与创新部(DAIRI)的试验启动流程进行重组项目,涉及临床试验中心(CTC)、伦理委员会秘书处(ESC)和行政协调(AC)三个部门,采用精益思维(Lean Thinking)方法和A3报告工具,通过监测关键绩效指标进行分析,项目包括分析、实施对策和监测时间线三个阶段,共八个4个月监测周期。
主要发现
- 共监测298项研究,包括研究协会和产业界赞助的观察性和干预性研究设计。
- 试验启动平均时间从项目前的218天降至最后监测期的56天。
- 从第一个到最后一个监测期,每个参与部门在其活动平均时间上至少减半:临床试验中心(CTC)从55天降至23天,伦理委员会秘书处(ECS)从25天降至8天,行政协调(AC)从29天降至10天。
- 签署协议的研究平均启动时间长于未签署协议者(100天 vs 46天)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: In order to make the centers more attractive to trial sponsors, in recent years, some research institutions around the world have pursued projects to reorganize the pathway of trial activation, developing new organizational models to improve the activation process and reduce its times. This study aims at analyzing and reorganizing the start-up phase of trials conducted at the Research and Innovation Department (DAIRI) of the Public Hospital of Alessandria (Italy). METHODS: A project was carried out to reorganize the trial authorization process at DAIRI by involving the three facilities responsible for this pathway: clinical trial center (CTC), ethics committee secretariat (ESC), and administrative coordination (AC). Lean Thinking methodology was used with the A3 report tool, and the analysis was carried out by monitoring specific key performance indicators, derived from variables representing highlights of the trials' activation pathway. The project involved phases of analysis, implementation of identified countermeasures, and monitoring of timelines in eight 4-month periods. The overall mean and median values of studies activation times were calculated as well as the average times for each facility involved in the process. RESULTS: In this study, 298 studies both sponsored by research associations and industry with both observational and interventional study design were monitored. The mean trial activation time was reduced from 218 days before the project to 56 days in the last period monitored. From the first to the last monitoring period, each facility involved achieved at least a halving of the average time required to carry out its activities in the clinical trials' activation pathway (CTC: 55 days vs 23, ECS: 25 days vs 8, AC 29 days vs 10). Average activation time for studies with agreement remains longer than those without agreement (100 days vs. 46). CONCLUSIONS: The reorganization project emphasized the importance of having clinical and administrative staff specifically trained on the trial activation process. This reorganization led to the development of a standard operating procedure and a tool to monitor the time (KPIs of the process) that can also be implemented in other clinical centers.
引用
- Pelazza C, Betti M, Marengo F, et al. The clinical trial activation process: a case study of an Italian public hospital. Trials. 2024. PMID: 38581073. doi:10.1186/s13063-024-08059-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。